Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 511-514, 2006; 10.1373/clinchem.2005.058537
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Endler, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Endler, G.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Clinical Immunology
(Clinical Chemistry. 2006;52:511-514.)
© 2006 American Association for Clinical Chemistry, Inc.

Technical Briefs

Polymorphisms in the Interleukin-1 Gene Cluster in Children and Young Adults with Systemic Meningococcemia

Georg Endler3,1, Rodrig Marculescu3,1, Philipp Starkl3, Alexander Binder1, Gotho Geishofer1, Martin Müller1, Bettina Zöhrer1, Bernhard Resch2, Werner Zenz1,2, Christine Mannhalter3,2,a for the Central European Meningococcal Genetic Study Group

(Departments of1 General Pediatrics and2 Neonatology, Medical University of Graz, Graz, Austria;3 Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Vienna, Vienna, Austria;

aaddress correspondence to this author at: Clinical Institute of Medical and Chemical Laboratory Diagnostic, Medical University Vienna, Vienna, Austria, Waehringer Guertel 18-20, 1090 Wien, Austria; fax 43-1-40400-2097, e-mail christine.mannhalter{at}meduniwien.ac.at)


Abstract

Background: An association has been described between mortality in children with meningococcal disease and functional polymorphisms in the interleukin-1 (IL1) cluster. We undertook a multicenter study to evaluate associations of these polymorphisms in a Central European population.

Patients and Methods: The study involved 95 Middle European pediatric hospitals. We collected blood samples from, and clinical information about, 285 previously healthy children with meningococcal infection. We used a newly developed multiplexed mutagenic separated PCR assay to analyze 6 polymorphisms within the IL1 cluster: IL1A (–889)C/T, IL1A (+4845)G/T, IL1B (–511)C/T, IL1B (–31)C/T, IL1B (+3954), and IL1RA (+2018)C/T. We studied the same polymorphisms in a comparison group of 481 healthy newborns.

Results: Genotype frequencies between patients and the comparison group differed significantly only for the IL1RA (+2018)C/T variant: The CC genotype was more frequent in patients (11%) than in healthy controls (5%; P = 0.008). In the patient group, the C allele was significantly more prevalent (67%) in nonsurvivors than in survivors (42%; P = 0.02).

Conclusion: The IL1RA (+2018)C/T polymorphism is associated with the risk of meningococcal disease and with its outcome.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.